<rss version="2.0">
<channel>
<title>IBTimes.com RSS Feed - Drugs &amp; Healthcare</title>
<description>International Business News - Drugs &amp; Healthcare</description>
<link>http://hk.ibtimes.com/subsection/companies/drugshealth.htm</link>
<copyright>All articles are copyrighted by IBTimes.com</copyright>

<image>
	<title>The International Business Times - Business News, Updated daily</title> 
	<width>400</width> 
	<height>100</height> 
	<link>http://hk.ibtimes.com/</link> 
	<url>http://hk.ibtimes.com/images/top_logo_ibt2_3.gif</url> 
</image>


  <item>
  <title>Teva to buy Barr Pharma for more than $7 billion</title>
  <description>Teva Pharmaceutical said Friday it will buy rival generic drugmaker Barr Pharmaceuticals for nearly $7.5 billion in a move that will boost Teva&amp;#039;s dominance as the world&amp;#039;s biggest generic drugmaker.</description>
    <link>http://hk.ibtimes.com/articles/20080721/teva.htm</link> 
  <pubDate>Mon, 21 Jul 2008 08:35:34 EDT</pubDate>
  </item>


  <item>
  <title>Glenmark gets USFDA nod for generic anti-hypertension drug Trandolapril</title>
  <description>Glenmark Generics Ltd, a unit of India&amp;#039;s Glenmark Pharmaceuticals Ltd, has received the nod from the US Food and Drug Administration (USFDA) for the sale of its generic version of anti-hypertension drug, Trandolapril.</description>
    <link>http://hk.ibtimes.com/articles/20080624/glenmark-usfda-anti-hypertension-drug-trandolapril.htm</link> 
  <pubDate>Tue, 24 Jun 2008 11:00:11 EDT</pubDate>
  </item>


  <item>
  <title>Philip Morris USA pulls new filter cigarettes</title>
  <description>Philip Morris USA, the nation&amp;#039;s No. 1 tobacco company, said Monday it has ended test markets of Marlboro-branded cigarettes that use a high-technology filter.</description>
    <link>http://hk.ibtimes.com/articles/20080624/philip-morris.htm</link> 
  <pubDate>Tue, 24 Jun 2008 09:18:30 EDT</pubDate>
  </item>


  <item>
  <title>Ranbaxy settles patent dispute with Pfizer over Lipitor, other drugs</title>
  <description>India&amp;#039;s largest generics durgmaker Rnbaxy Laboratories, which has agreed to become a subsidiary of Japanese drugmaker Daiichi Sankyo for $4.6 billion, pulled off a coup of sorts, announcing it has settled certain patent disputes with Pfizer over its $13 billion blockbuster anti-cholesterol drug Lipitor (generic name Atorvastatin) and other drugs.</description>
    <link>http://hk.ibtimes.com/articles/20080616/ranbaxy-settles-patent-dispute-pfizer-lipitor-drugs.htm</link> 
  <pubDate>Mon, 16 Jun 2008 15:59:29 EDT</pubDate>
  </item>


  <item>
  <title>Japanese drugmaker Daiichi Sankyo gobbles Ranbaxy Laboratories for $4.6 billion</title>
  <description>In what is seen as India&amp;#039;s biggest acquisition deal in the pharmaceutical sector, Japanese drugmaker Daiichi Sankyo Co. said it has reached an agreement with India&amp;#039;s largest generics drugmaker Ranbaxy Laboratories Ltd. which will see the former acquire the latter&amp;#039;s majority stake for around $4.6 billion (£2.3 billion).</description>
    <link>http://hk.ibtimes.com/articles/20080614/japanese-drugs-maker-daiici.htm</link> 
  <pubDate>Sat, 14 Jun 2008 12:30:16 EDT</pubDate>
  </item>


  <item>
  <title>U.S. Senator requests FDA to Scrutinize Glaxo&amp;#039;s Antidepressant Data</title>
  <description>U.S. senator Charles Grassley asked to scrutinize if the drug maker GlaxoSmithKline Plc withheld safety information that linked its drug Paxil to suicide risk.</description>
    <link>http://hk.ibtimes.com/articles/20080613/fda-scrutinize-glaxo-antidepressant-data.htm</link> 
  <pubDate>Fri, 13 Jun 2008 15:00:16 EDT</pubDate>
  </item>


  <item>
  <title>Martek Biosciences 2Q profit surpasses forecasts</title>
  <description>Martek Biosciences Corp. said on Wednesday its second quarter net income was $9.2 million or 28 cents a share, surpassing analysts forecasts.</description>
    <link>http://hk.ibtimes.com/articles/20080606/martek.htm</link> 
  <pubDate>Fri, 06 Jun 2008 09:23:11 EDT</pubDate>
  </item>


  <item>
  <title>Merck&amp;#039;s Osteoporosis drug enters Phase III trial</title>
  <description>Merck &amp; Co. reported a Phase III trial which studies odanacatib for the treatment of osteoporosis in postmenopausal woman is underway which will include tests for breast and prostate cancer.</description>
    <link>http://hk.ibtimes.com/articles/20080530/merck.htm</link> 
  <pubDate>Fri, 30 May 2008 09:31:26 EDT</pubDate>
  </item>


  <item>
  <title>Favrille Inc. shares Slump near 90% as it discontinues Specifid Cancer Drug</title>
  <description>Biopharmaceutical group Favrille Inc. shares slumped near 90 percent on Tuesday after the company said it will stop the development of its lead cancer drug, Specifid, as it failed to meet a strategic goal in a late stage trial.</description>
    <link>http://hk.ibtimes.com/articles/20080528/favrille-inc.htm</link> 
  <pubDate>Wed, 28 May 2008 10:47:25 EDT</pubDate>
  </item>


  <item>
  <title>Avanir&amp;#039;s Diabetic Drug shows positive results on Trial</title>
  <description>Today the company said the new formulation of Zenvia will improve the cardiovascular risk profile since it offers a lower exposure to the pharmaceutical agent quinidine</description>
    <link>http://hk.ibtimes.com/articles/20080528/avanir-039-diabetic-drug.htm</link> 
  <pubDate>Wed, 28 May 2008 10:42:24 EDT</pubDate>
  </item>


  <item>
  <title>Chinese medicine import value up 11.8%</title>
  <description>The total import value of Chinese herbal medicines rose 11.8% last year to $1.69 billion, with a significant portion consumed locally, a Census &amp; Statistics Department study has found.</description>
    <link>http://hk.ibtimes.com/articles/20080522/chinese-medicine-import.htm</link> 
  <pubDate>Thu, 22 May 2008 12:09:09 EDT</pubDate>
  </item>


  <item>
  <title>Pfizer&amp;#039;s Chantrix anti-smoking pill banned on Side Effects Study</title>
  <description>Anti-Smoking pill Chantrix from Pfizer Inc. was banned today by the Federal Aviation Administration for its use by pilots and air traffic controlers, after a study showed dangerous side effects.</description>
    <link>http://hk.ibtimes.com/articles/20080522/pfizer-039-chantrix.htm</link> 
  <pubDate>Thu, 22 May 2008 08:45:43 EDT</pubDate>
  </item>


  <item>
  <title>Merck to Pay $58 Mil to Settle Vioxx Advertising Case</title>
  <description>Merck &amp; Co. said on Tuesday it agreed to pay $58 million to settle allegations that its ads for the once-popular painkiller Vioxx deceptively played down the health risks in 29 states, including the District of Columbia.</description>
    <image>
  <url>http://hk.ibtimes.com/data/articleimgs/2027-merck-to-pay-58-mil-to-settle-vioxx-advertising-case.jpg</url>
  <link>http://hk.ibtimes.com/articles/20080521/merck.htm</link>
  </image>
    <link>http://hk.ibtimes.com/articles/20080521/merck.htm</link> 
  <pubDate>Wed, 21 May 2008 09:34:24 EDT</pubDate>
  </item>


  <item>
  <title>Immucor Replies to FDA Warning Letter, Shares Fall near 5 Pct</title>
  <description>Immucor Inc. replied on Tuesday to a warning letter from the Food and Drug Administration that pointed out problems of manufacturing practices in the company.</description>
    <link>http://hk.ibtimes.com/articles/20080514/immucor.htm</link> 
  <pubDate>Wed, 14 May 2008 11:34:38 EDT</pubDate>
  </item>


  <item>
  <title>Natus Medical Plans to Offer $3.5 Million Common Shares</title>
  <description>Natus Medical Inc. developer and manufacturer of medical devices fore newborns said Tuesday it is planning to make a public offering of 3.5 million common shares.</description>
    <link>http://hk.ibtimes.com/articles/20080514/natus-medical.htm</link> 
  <pubDate>Wed, 14 May 2008 11:26:28 EDT</pubDate>
  </item>


  <item>
  <title>Stryker reveals $50 Million Investment on Quality, Compliance</title>
  <description>Stryker Corp. said today it will invest $50 million in 2008 to improve its quality systems and compliance at the time it deals with three warning letters from the U.S. Food and Drug Administration.</description>
    <link>http://hk.ibtimes.com/articles/20080509/stryker.htm</link> 
  <pubDate>Fri, 09 May 2008 08:40:34 EDT</pubDate>
  </item>


  <item>
  <title>Mylan 1Q Profit Slumps on Charges</title>
  <description>Mylan Inc. manufacturer of generic pharmaceutical products said on Thursday an extended first quarter loss and a large increase on its revenue triggered by the purchase of Merck KGaA in October.</description>
    <link>http://hk.ibtimes.com/articles/20080509/mylan.htm</link> 
  <pubDate>Fri, 09 May 2008 08:37:37 EDT</pubDate>
  </item>


  <item>
  <title>United Drug profits up 15%</title>
  <description>United Drug said that its dividend per share also rose 13 per cent to 2.23 cents.</description>
    <link>http://hk.ibtimes.com/articles/20080507/united-drug.htm</link> 
  <pubDate>Wed, 07 May 2008 14:44:00 EDT</pubDate>
  </item>


  <item>
  <title>Merck Cuts 1,200 sales jobs amid Non Approval of Cordaptive</title>
  <description>The number of cuts represents 15 percent of Merck&amp;#039;s US sales force of 8,500 at the beginning of 2007. Affected employees will be notified by the end of May and they will leave by the end of July with</description>
    <link>http://hk.ibtimes.com/articles/20080506/merck.htm</link> 
  <pubDate>Tue, 06 May 2008 08:38:20 EDT</pubDate>
  </item>


  <item>
  <title>Opening glance: health care equipment and supply stocks rise</title>
  <description>Shares of health care equipment and supply companies rose in early trading Friday, one day after Varian Medical Systems Inc. said its first-quarter profit topped Wall Street&amp;#039;s estimates.</description>
    <link>http://hk.ibtimes.com/articles/20080424/health-care.htm</link> 
  <pubDate>Thu, 24 Apr 2008 14:44:38 EDT</pubDate>
  </item>


</channel>
</rss>